ENTITY
Grifols

Grifols (GRFS US)

41
Analysis
Health Care • Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
Company Event • 04 Nov 2026 01:30 • Upcoming
Add To Calendar

Q3 2026

Company Event • 27 Feb 2027 00:35 • Upcoming
Add To Calendar

Q4 2026

Company Event • 29 Jul 2026 00:30 • Latest

Q2 2026

Company Event • 08 May 2026 00:30

Q1 2026

Company Event • 13 Mar 2026 20:00 • Upcoming
Add To Calendar

Proxy Filing

x